Methylthioninium chloride Cosmo is used in adults as a dye to help doctors see the lining of the colon (large bowel) more clearly and improve detection of lesions (abnormalities) during colonoscopy, a procedure to examine the colon through a tube with a camera. Methylthioninium chloride Cosmo contains the active substance methylthioninium chloride. Methylthioninium chloride Cosmo is a ‘hybrid medicine’. This means that it is similar to a ‘reference medicine’ containing the same active substance, but the authorised use, strength, pharmaceutical form and route of administration are different. The reference medicine for Methylthioninium chloride Cosmo is Metilénkék Pharmamagist, a medicine authorised in Hungary.
Therapeutic Indication
### Therapeutic indication Lumeblue is indicated as a diagnostic agent enhancing visualisation of colorectal lesions in adult patients undergoing screening or surveillance colonoscopy.
Therapeutic Area (MeSH)
ATC Code
V04CX
ATC Item
其它诊断试剂
Pharmacotherapeutic Group
Other diagnostic agents
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| methylthioninium chloride | N/A | 亚甲蓝 |
EMA Name
Lumeblue (previously known as Methylthioninium chloride Cosmo)
Medicine Name
Lumeblue (previously Methylthioninium chloride Cosmo)
Aliases
N/ANo risk management plan link.